-       Report 
- November 2023
-  120 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- May 2022
-  101 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- March 2025
-  214 Pages 
- China 
   From       €3578EUR$4,000USD£3,147GBP 
          -       Report 
- March 2025
-  65 Pages 
- China 
   From       €1610EUR$1,800USD£1,416GBP 
          -       Report 
- November 2021
-  747 Pages 
- Global 
   From       €3578EUR$4,000USD£3,147GBP 
                  The Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. These drugs are used to target and destroy cancer cells, reduce the size of tumors, and reduce the spread of cancer. Tumor drugs are typically divided into two categories: cytotoxic drugs, which kill cancer cells, and targeted therapies, which target specific molecules involved in cancer growth. These drugs are often used in combination with other treatments, such    as radiation and surgery, to maximize the effectiveness of treatment.
The Tumor Drug market is highly competitive, with many companies developing and selling drugs to treat cancer. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as AstraZeneca, Eli Lilly, and Amgen, are also active in the market. Show Less   Read more